Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medical Device Reporting: Manufacturer, Importer, User Facility, and Distributor Reporting, 51820-51822 [2015-21036]
Download as PDF
51820
Federal Register / Vol. 80, No. 165 / Wednesday, August 26, 2015 / Notices
FEE SCHEDULE FOR EACH VESSEL
SIZE
Inspection
fee
Vessel size (GRT 1)
Extra Small (<3,000 GRT) ....
Small (3,001–15,000 GRT) ..
Medium (15,001–30,000
GRT) .................................
Large (30,001–60,000 GRT)
Extra Large (60,001–120,000
GRT) .................................
Mega (>120,001 GRT) .........
US$1,495
2,990
Dated: August 19, 2015.
Pamela J. Cox,
Director, Division of the Executive Secretariat,
Office of the Chief of Staff, Centers for Disease
Control and Prevention.
[FR Doc. 2015–21107 Filed 8–25–15; 8:45 am]
BILLING CODE 4163–18–P
5,980
8,970
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
11,960
17,940
Administration for Children and
Families
1 Gross register tonnage in cubic feet, as
shown in Lloyd’s Register of Shipping.
Proposed Information Collection
Activity; Comment Request
Proposed Projects:
Title: State Self-Assessment Review
and Report.
OMB No.: 0970–0223.
Description: Section 454(15)(A) of the
Social Security Act, as amended by the
Personal Responsibility and Work
Opportunity Reconciliation Act of 1996,
requires each State to annually assess
the performance of its child support
enforcement program in accordance
with standards specified by the
Secretary of the Department of Health
and Human Services, and to provide a
report of the findings to the Secretary.
This information is required to
determine if States are complying with
Federal child support mandates and
providing the best services possible. The
report is also intended to be used as a
management tool to help States evaluate
their programs and assess performance.
Respondents: State Child Support
Enforcement Agencies or the
Department/Agency/Bureau responsible
for Child Support Enforcement in each
State.
ANNUAL BURDEN ESTIMATES
Number of
respondents
Number of
responses per
respondent
Average burden
hours per
response
Total burden
hours
Self-assessment report ............................................................
rmajette on DSK7SPTVN1PROD with NOTICES
Instrument
54
1
4
216
Estimated Total Annual Burden
Hours: 216.
In compliance with the requirements
of Section 506(c)(2)(A) of the Paperwork
Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Planning, Research
and Evaluation, 370 L’Enfant
Promenade SW., Washington, DC 20447,
Attn: ACF Reports Clearance Officer.
Email address: infocollection@
acf.hhs.gov. All requests should be
identified by the title of the information
collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
VerDate Sep<11>2014
14:29 Aug 25, 2015
Jkt 235001
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2015–21053 Filed 8–25–15; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0110]
Fax written comments on the
collection of information by September
25, 2015.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0437. Also
include the FDA docket number found
in brackets in the heading of this
document.
DATES:
FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002,
PRAStaff@fda.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Medical Device
Reporting: Manufacturer, Importer,
User Facility, and Distributor Reporting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
SUMMARY:
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
Medical Device Reporting:
Manufacturer, Importer, User Facility,
and Distributor Reporting (21 CFR Part
803)—(OMB Control Number 0910–
0437)—Revision
Section 519(a)(1) of the Federal Food,
Drug, and Cosmetic Act (the FD&C Act)
E:\FR\FM\26AUN1.SGM
26AUN1
rmajette on DSK7SPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 165 / Wednesday, August 26, 2015 / Notices
(21 U.S.C. 360i(a)(1)) requires every
manufacturer or importer to report
whenever the manufacturer or importer
receives or otherwise becomes aware of
information that reasonably suggests
that one of its marketed devices may
have caused or contributed to a death or
serious injury or has malfunctioned and
that such device or a similar device
marketed by the manufacturer or
importer would be likely to cause or
contribute to a death or serious injury if
the malfunction were to recur.
Section 519(b)(1)(A) of the FD&C Act
requires whenever a device user facility
receives or otherwise becomes aware of
information that reasonably suggests
that a device has or may have caused or
contributed to the death or serious
illness, of a patient of the facility, the
facility shall, as soon as practicable but
not later than 10 working days after
becoming aware of the information,
report the information to the Secretary
of HHS and, if the identity of the
manufacturer is known, to the
manufacturer of the device.
Section 519(b)(1)(B) of the FD&C Act
requires whenever a device user facility
receives or otherwise becomes aware of
information that reasonably suggests
that a device has or may have caused or
contributed to the serious illness of, or
serious injury to, a patient of the
facility, shall, as soon as practicable but
not later than 10 working days after
becoming aware of the information,
report the information to the
manufacturer of the device or to the
Secretary of HHS if the identity of the
manufacturer is not known.
Complete, accurate, and timely
adverse event information is necessary
for the identification of emerging device
problems. Information from these
reports will be used to evaluate risks
associated with medical devices which
will enable FDA to take appropriate
regulatory measures in protection of the
public health under section 519 of the
FD&C Act. Thus FDA is requesting
approval for these information
collection requirements which are being
implemented under part 803 (21 CFR
part 803).
Respondents to this collection of
information are businesses or other forprofit and nonprofit organizations
including user facilities, manufacturers,
and importers of medical devices.
Part 803 requires user facilities to
report to the device manufacturer and to
FDA in case of a death, incidents where
a medical device caused or contributed
to a death or serious injury.
Additionally, user facilities are required
to annually submit the number and
summary of adverse events reported
during the calendar year using Form
VerDate Sep<11>2014
14:29 Aug 25, 2015
Jkt 235001
FDA 3419. Manufacturers of medical
devices are required to report to FDA
when they become aware of information
indicating that one of their devices may
have caused or contributed to death or
serious injury or has malfunctioned in
such a way, that should the malfunction
recur, it would be likely to cause or
contribute to a death or serious injury.
Device importers report deaths and
serious injuries to the manufacturers
and FDA. Importers report malfunctions
only to the manufacturers, unless they
are unknown, then the reports are sent
to FDA.
The number of respondents for each
Code of Federal Regulations (CFR)
section in table 1 is based upon the
number of respondents entered into
FDA’s internal databases. FDA
estimates, based on its experience and
interaction with the medical device
community, that all reporting CFR
sections are expected to take 1 hour to
complete, with the exception of
§ 803.19. Section 803.19 is expected to
take approximately 3 hours to complete,
but is only required for reporting the
summarized data quarterly to FDA. By
summarizing events, the total time used
to report for this section is reduced
because the respondents do not submit
a full report for each event they report
in a quarterly summary report.
The Agency believes that the majority
of manufacturers, user facilities, and
importers have already established
written procedures to document
complaints and information to meet the
medical device reporting (MDR)
requirements as part of their internal
quality control system. There are an
estimated 30,000 medical device
distributors. Although they do not
submit MDR reports, they must
maintain records of complaints under
§ 803.18(d).
The Agency has estimated that on
average 220 user facilities, importers,
and manufacturers would annually be
required to establish new procedures, or
revise existing procedures, in order to
comply with this provision.
Therefore, FDA estimates the onetime burden to respondents for
establishing or revising procedures
under § 803.17 to be 6,006 hours (1,820
respondents × 3.3 hours). For those
entities, a one-time burden of 3.3 hours
is estimated for establishing written
MDR procedures. The remaining
manufacturers, user facilities, and
importers, not required to revise their
written procedures to comply with this
provision, are excluded from the burden
because the recordkeeping activities
needed to comply with this provision
are considered ‘‘usual and customary’’
under 5 CFR 1320.3(b)(2).
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
51821
Under § 803.18, 1,820 respondents
represent distributors, importers, and
other respondents to this information
collection. FDA estimates that it should
take them approximately 1.5 hours to
complete the recordkeeping requirement
for this section. Total hours for this
section equal 2,730 hours.
Reporting Requirements
Part 803 requires user facilities to
report incidents where a medical device
caused or contributed a death or serious
injury to the device manufacturer and to
FDA in the case of a death.
Manufacturers of medical devices are
required to report to FDA when they
become aware of information indicating
that one of their devices may have
caused or contributed to death or
serious injury or has malfunctioned in
such a way that, should the malfunction
recur, it would be likely to cause or
contribute to a death or serious injury.
Device importers report deaths and
serious injuries to the manufacturers
and FDA. Importers report malfunctions
only to the manufacturers (see thirdparty disclosure burden table), unless
the manufacturers are unknown, then
the reports are sent to FDA.
FDA estimates are based on our
experience and interaction with the
medical device community and burden
analysis from the rulemaking. Section
803.19 is expected to take
approximately 1 hour to complete, but
is only required to report the
summarized data quarterly to FDA. By
summarizing events, the total time used
to report for this section is reduced
because the respondents do not submit
a full report for each event they report
in a quarterly summary report.
Recordkeeping Requirements
The Agency believes that the majority
of manufacturers, user facilities, and
importers have already established
written procedures to document
complaints and information to meet the
MDR requirements as part of their
internal quality control system. The
Agency has estimated that on average,
1,820 user facilities, importers, and
manufacturers would annually be
required, under § 803.17, to establish
new procedures, or revise existing
procedures, in order to comply with this
provision. We estimate that it will take
each respondent 3.3 hours annually to
establish new procedures, or revise
existing procedures. We estimate that it
will take each respondent 1.5 hours
annually to maintain the records.
Third-Party Disclosure Burden
Under §§ 803.40 and 803.42, device
importers report deaths and serious
E:\FR\FM\26AUN1.SGM
26AUN1
51822
Federal Register / Vol. 80, No. 165 / Wednesday, August 26, 2015 / Notices
injuries to the manufacturers and FDA.
Importers report malfunctions only to
the manufacturers, unless they are
unknown, then the reports are sent to
FDA. We estimate that it will take
respondents 0.35 hours annually to
report the information.
In the Federal Register of May 07,
2015 (80 FR 26278), FDA published a
60-day notice requesting public
comment on the proposed collection of
information. No comments were
received. However, since the 60-day
notice, we have updated the burden
estimates to reflect revisions made by
the final rule, ‘‘Medical Device
Reporting: Electronic Submission
Requirements,’’ which became effective
August 14, 2015.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of
responses per
respondent
Number of
respondents
Average
burden per
response
Total annual
responses
21 CFR Section
FDA Form No.
Exemptions—803.19 ................................
User Facility Reporting—803.30 and
803.32 ...................................................
User Facility Annual Reporting—803.33
Importer Reporting, Death and Serious
Injury—803.40 and 803.42 ...................
Manufacturer
Reporting—803.50,
through 803.53 .....................................
Supplemental Reports—803.56 ...............
........................
56
4
224
1
224
........................
3419
520
520
7
1
3,640
520
0.35
1
1,274
520
........................
1
1
1
1
1
........................
........................
1,240
1,050
204
94
252,960
98,700
0.10
0.10
25,296
9,870
Total ..................................................
........................
........................
........................
........................
........................
37,185
1 There
Total hours
are no capital costs or operating and maintenance costs associated with this collection of information.
TABLE 2—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1
Number of
recordkeepers
21 CFR Section
Number of
records per
recordkeeper
Average
burden per
recordkeeping
Total annual
records
Total hours
MDR Procedures—803.17 ...................................................
MDR Files—803.18 ..............................................................
1,820
1,820
1
1
1,820
1,820
3.3
1.5
6,006
2,730
Total ..............................................................................
........................
........................
........................
........................
47,200
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
TABLE 3—ESTIMATED ANNUAL THIRD-PARTY DISCLOSURE BURDEN 1
21 CFR Section
Number of
respondents
Number of
disclosures
per
respondent
Total annual
disclosures
Average
burden per
disclosure
Total hours
Importer Reporting, Malfunctions—803.40 and 803.42 .......
60
25
1,500
0.35
525
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
Dated: August 20, 2015.
Leslie Kux,
Associate Commissioner for Policy.
Notice of draft guidance
availability and public meeting; request
for comments; extension of comment
period.
ACTION:
[FR Doc. 2015–21036 Filed 8–25–15; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
rmajette on DSK7SPTVN1PROD with NOTICES
[Docket No. FDA–2015–D–2537]
Request for Quality Metrics; Notice of
Draft Guidance Availability and Public
Meeting; Request for Comments;
Extension of Comment Period
AGENCY:
Food and Drug Administration,
HHS.
VerDate Sep<11>2014
14:29 Aug 25, 2015
The Food and Drug
Administration (FDA) is extending the
comment period for the notice of draft
guidance availability and public
meeting that appeared in the Federal
Register of July 28, 2015, and August 7,
2015. In the notice of draft guidance
availability and public meeting, FDA
requested comments on a number of
specific questions identified in the
document. The Agency is taking this
action in response to requests for an
extension to allow interested persons
additional time to submit comments.
DATES: FDA is extending the comment
period on the notice of draft guidance
SUMMARY:
Jkt 235001
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
availability and public meeting
published July 28, 2015 (80 FR 44973)
and August 7, 2015 (80 FR 47493).
Submit either electronic or written
comments by November 27, 2015.
ADDRESSES: You may submit comments
by any of the following methods:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
Written Submissions
Submit written submissions in the
following ways:
• Mail/Hand delivery/Courier (for
paper submissions): Division of Dockets
Management (HFA–305), Food and Drug
E:\FR\FM\26AUN1.SGM
26AUN1
Agencies
[Federal Register Volume 80, Number 165 (Wednesday, August 26, 2015)]
[Notices]
[Pages 51820-51822]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-21036]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2012-N-0110]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Medical Device
Reporting: Manufacturer, Importer, User Facility, and Distributor
Reporting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.
DATES: Fax written comments on the collection of information by
September 25, 2015.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX: 202-395-7285, or emailed to oira_submission@omb.eop.gov. All
comments should be identified with the OMB control number 0910-0437.
Also include the FDA docket number found in brackets in the heading of
this document.
FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations,
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver
Spring, MD 20993-0002, PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Medical Device Reporting: Manufacturer, Importer, User Facility, and
Distributor Reporting (21 CFR Part 803)--(OMB Control Number 0910-
0437)--Revision
Section 519(a)(1) of the Federal Food, Drug, and Cosmetic Act (the
FD&C Act)
[[Page 51821]]
(21 U.S.C. 360i(a)(1)) requires every manufacturer or importer to
report whenever the manufacturer or importer receives or otherwise
becomes aware of information that reasonably suggests that one of its
marketed devices may have caused or contributed to a death or serious
injury or has malfunctioned and that such device or a similar device
marketed by the manufacturer or importer would be likely to cause or
contribute to a death or serious injury if the malfunction were to
recur.
Section 519(b)(1)(A) of the FD&C Act requires whenever a device
user facility receives or otherwise becomes aware of information that
reasonably suggests that a device has or may have caused or contributed
to the death or serious illness, of a patient of the facility, the
facility shall, as soon as practicable but not later than 10 working
days after becoming aware of the information, report the information to
the Secretary of HHS and, if the identity of the manufacturer is known,
to the manufacturer of the device.
Section 519(b)(1)(B) of the FD&C Act requires whenever a device
user facility receives or otherwise becomes aware of information that
reasonably suggests that a device has or may have caused or contributed
to the serious illness of, or serious injury to, a patient of the
facility, shall, as soon as practicable but not later than 10 working
days after becoming aware of the information, report the information to
the manufacturer of the device or to the Secretary of HHS if the
identity of the manufacturer is not known.
Complete, accurate, and timely adverse event information is
necessary for the identification of emerging device problems.
Information from these reports will be used to evaluate risks
associated with medical devices which will enable FDA to take
appropriate regulatory measures in protection of the public health
under section 519 of the FD&C Act. Thus FDA is requesting approval for
these information collection requirements which are being implemented
under part 803 (21 CFR part 803).
Respondents to this collection of information are businesses or
other for-profit and nonprofit organizations including user facilities,
manufacturers, and importers of medical devices.
Part 803 requires user facilities to report to the device
manufacturer and to FDA in case of a death, incidents where a medical
device caused or contributed to a death or serious injury.
Additionally, user facilities are required to annually submit the
number and summary of adverse events reported during the calendar year
using Form FDA 3419. Manufacturers of medical devices are required to
report to FDA when they become aware of information indicating that one
of their devices may have caused or contributed to death or serious
injury or has malfunctioned in such a way, that should the malfunction
recur, it would be likely to cause or contribute to a death or serious
injury. Device importers report deaths and serious injuries to the
manufacturers and FDA. Importers report malfunctions only to the
manufacturers, unless they are unknown, then the reports are sent to
FDA.
The number of respondents for each Code of Federal Regulations
(CFR) section in table 1 is based upon the number of respondents
entered into FDA's internal databases. FDA estimates, based on its
experience and interaction with the medical device community, that all
reporting CFR sections are expected to take 1 hour to complete, with
the exception of Sec. 803.19. Section 803.19 is expected to take
approximately 3 hours to complete, but is only required for reporting
the summarized data quarterly to FDA. By summarizing events, the total
time used to report for this section is reduced because the respondents
do not submit a full report for each event they report in a quarterly
summary report.
The Agency believes that the majority of manufacturers, user
facilities, and importers have already established written procedures
to document complaints and information to meet the medical device
reporting (MDR) requirements as part of their internal quality control
system. There are an estimated 30,000 medical device distributors.
Although they do not submit MDR reports, they must maintain records of
complaints under Sec. 803.18(d).
The Agency has estimated that on average 220 user facilities,
importers, and manufacturers would annually be required to establish
new procedures, or revise existing procedures, in order to comply with
this provision.
Therefore, FDA estimates the one-time burden to respondents for
establishing or revising procedures under Sec. 803.17 to be 6,006
hours (1,820 respondents x 3.3 hours). For those entities, a one-time
burden of 3.3 hours is estimated for establishing written MDR
procedures. The remaining manufacturers, user facilities, and
importers, not required to revise their written procedures to comply
with this provision, are excluded from the burden because the
recordkeeping activities needed to comply with this provision are
considered ``usual and customary'' under 5 CFR 1320.3(b)(2).
Under Sec. 803.18, 1,820 respondents represent distributors,
importers, and other respondents to this information collection. FDA
estimates that it should take them approximately 1.5 hours to complete
the recordkeeping requirement for this section. Total hours for this
section equal 2,730 hours.
Reporting Requirements
Part 803 requires user facilities to report incidents where a
medical device caused or contributed a death or serious injury to the
device manufacturer and to FDA in the case of a death. Manufacturers of
medical devices are required to report to FDA when they become aware of
information indicating that one of their devices may have caused or
contributed to death or serious injury or has malfunctioned in such a
way that, should the malfunction recur, it would be likely to cause or
contribute to a death or serious injury. Device importers report deaths
and serious injuries to the manufacturers and FDA. Importers report
malfunctions only to the manufacturers (see third-party disclosure
burden table), unless the manufacturers are unknown, then the reports
are sent to FDA.
FDA estimates are based on our experience and interaction with the
medical device community and burden analysis from the rulemaking.
Section 803.19 is expected to take approximately 1 hour to complete,
but is only required to report the summarized data quarterly to FDA. By
summarizing events, the total time used to report for this section is
reduced because the respondents do not submit a full report for each
event they report in a quarterly summary report.
Recordkeeping Requirements
The Agency believes that the majority of manufacturers, user
facilities, and importers have already established written procedures
to document complaints and information to meet the MDR requirements as
part of their internal quality control system. The Agency has estimated
that on average, 1,820 user facilities, importers, and manufacturers
would annually be required, under Sec. 803.17, to establish new
procedures, or revise existing procedures, in order to comply with this
provision. We estimate that it will take each respondent 3.3 hours
annually to establish new procedures, or revise existing procedures. We
estimate that it will take each respondent 1.5 hours annually to
maintain the records.
Third-Party Disclosure Burden
Under Sec. Sec. 803.40 and 803.42, device importers report deaths
and serious
[[Page 51822]]
injuries to the manufacturers and FDA. Importers report malfunctions
only to the manufacturers, unless they are unknown, then the reports
are sent to FDA. We estimate that it will take respondents 0.35 hours
annually to report the information.
In the Federal Register of May 07, 2015 (80 FR 26278), FDA
published a 60-day notice requesting public comment on the proposed
collection of information. No comments were received. However, since
the 60-day notice, we have updated the burden estimates to reflect
revisions made by the final rule, ``Medical Device Reporting:
Electronic Submission Requirements,'' which became effective August 14,
2015.
FDA estimates the burden of this collection of information as
follows:
Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
21 CFR Section FDA Form No. Number of responses per Total annual Average burden Total hours
respondents respondent responses per response
--------------------------------------------------------------------------------------------------------------------------------------------------------
Exemptions--803.19...................................... .............. 56 4 224 1 224
User Facility Reporting--803.30 and 803.32.............. .............. 520 7 3,640 0.35 1,274
User Facility Annual Reporting--803.33.................. 3419 520 1 520 1 520
Importer Reporting, Death and Serious Injury--803.40 and .............. 1 1 1 1 1
803.42.................................................
Manufacturer Reporting--803.50, through 803.53.......... .............. 1,240 204 252,960 0.10 25,296
Supplemental Reports--803.56............................ .............. 1,050 94 98,700 0.10 9,870
-----------------------------------------------------------------------------------------------
Total............................................... .............. .............. .............. .............. .............. 37,185
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
Table 2--Estimated Annual Recordkeeping Burden \1\
----------------------------------------------------------------------------------------------------------------
Number of Average burden
21 CFR Section Number of records per Total annual per Total hours
recordkeepers recordkeeper records recordkeeping
----------------------------------------------------------------------------------------------------------------
MDR Procedures--803.17.......... 1,820 1 1,820 3.3 6,006
MDR Files--803.18............... 1,820 1 1,820 1.5 2,730
-------------------------------------------------------------------------------
Total....................... .............. .............. .............. .............. 47,200
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
Table 3--Estimated Annual Third-Party Disclosure Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
21 CFR Section Number of disclosures per Total annual Average burden Total hours
respondents respondent disclosures per disclosure
--------------------------------------------------------------------------------------------------------------------------------------------------------
Importer Reporting, Malfunctions--803.40 and 803.42................ 60 25 1,500 0.35 525
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
Dated: August 20, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-21036 Filed 8-25-15; 8:45 am]
BILLING CODE 4164-01-P